SLNO
Soleno Therapeutics Inc
NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY
$52.78
+0.04% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$29 – $90
Volume
3.8M
Soleno Therapeutics Inc (SLNO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.50M | $-885218.00 | $-4.48M | $-10.30M | $-13.50M | $-9.95M | $-11.68M | $-17.38M | $-25.22M | $-27.77M | $-20.78M | $-24.94M | $-69.10M | $46.80M |
| Capital expenditures | $2490.00 | $1274.00 | $30683.00 | $305777.00 | $38680.00 | $2569.00 | $8000.00 | $21000.00 | $7000.00 | $22000.00 | $13000.00 | $0.00 | $218000.00 | $73000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $24415.00 | $38417.00 | $345435.00 | $942369.00 | $871270.00 | $880031.00 | $988000.00 | $825000.00 | $1.50M | $3.28M | $2.53M | $5.95M | $99.96M | $45.85M |
| Free cash flow | $-3.50M | $-886492.00 | $-4.52M | $-10.61M | $-13.54M | $-9.95M | $-11.69M | $-17.40M | $-25.23M | $-27.79M | $-20.79M | $-24.94M | $-69.31M | $46.73M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $6.69M | $-2.46M | $-2.77M | $14.37M | $5.96M | $-2.37M | $28.49M | — | — | — | — | — |